Samyang Biopharmaceuticals Corporation
Samyang Biopharmaceuticals Corporation
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL. | primary central nervous system lymphoma | Recruiting | Phase 2 | 2026-04-23 | NCT04627753 | |
| A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds | Nasolabial Folds, Wrinkles | Recruiting | Not applicable | 2026-03-12 | NCT07467239 | |
| A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds | Nasolabial Folds, Wrinkles | Recruiting | Not applicable | 2026-03-05 | NCT07292779 | |
| A Study in Adults Evaluating Polycaprolactone Microsphere Filler for Treatment of Moderate to Severe Nasolabial Folds | Nasolabial Fold Correction | Not yet recruiting | Not applicable | 2025-05-08 | NCT06961448 |